74 related articles for article (PubMed ID: 20406096)
1. Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone.
Dass CR; Tan ML; Galloway SJ; Choong PF
Oligonucleotides; 2010 Apr; 20(2):79-91. PubMed ID: 20406096
[TBL] [Abstract][Full Text] [Related]
2. Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation.
Dass CR; Galloway SJ; Choong PF
Oligonucleotides; 2010 Jun; 20(3):137-46. PubMed ID: 20180631
[TBL] [Abstract][Full Text] [Related]
3. Dz13: c-Jun downregulation and tumour cell death.
Elahy M; Dass CR
Chem Biol Drug Des; 2011 Dec; 78(6):909-12. PubMed ID: 21722318
[TBL] [Abstract][Full Text] [Related]
4. Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration.
Dass CR; Choong PF
Oligonucleotides; 2010 Apr; 20(2):51-60. PubMed ID: 20148692
[TBL] [Abstract][Full Text] [Related]
5. Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death.
Gozar MM; Goodchild A; Passioura T; King A; Lai A; Witherington C; Rivory L
Oligonucleotides; 2008 Sep; 18(3):257-68. PubMed ID: 18699742
[TBL] [Abstract][Full Text] [Related]
6. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
Dass CR; Khachigian LM; Choong PF
Mol Cancer Res; 2008 Aug; 6(8):1289-92. PubMed ID: 18708361
[TBL] [Abstract][Full Text] [Related]
7. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.
Zhang G; Dass CR; Sumithran E; Di Girolamo N; Sun LQ; Khachigian LM
J Natl Cancer Inst; 2004 May; 96(9):683-96. PubMed ID: 15126605
[TBL] [Abstract][Full Text] [Related]
8. DNAzyme targeting c-jun suppresses skin cancer growth.
Cai H; Santiago FS; Prado-Lourenco L; Wang B; Patrikakis M; Davenport MP; Maghzal GJ; Stocker R; Parish CR; Chong BH; Lieschke GJ; Wong TW; Chesterman CN; Francis DJ; Moloney FJ; Barnetson RS; Halliday GM; Khachigian LM
Sci Transl Med; 2012 Jun; 4(139):139ra82. PubMed ID: 22723462
[TBL] [Abstract][Full Text] [Related]
9. Induction of caspase-2 activation by a DNA enzyme evokes tumor cell apoptosis.
Kim SH; Dass CR
DNA Cell Biol; 2012 Jan; 31(1):1-7. PubMed ID: 22077397
[TBL] [Abstract][Full Text] [Related]
10. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
11. The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.
Rivory L; Tucker C; King A; Lai A; Goodchild A; Witherington C; Gozar MM; Birkett DJ
Oligonucleotides; 2006; 16(4):297-312. PubMed ID: 17155906
[TBL] [Abstract][Full Text] [Related]
12. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
[TBL] [Abstract][Full Text] [Related]
13. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.
Fahmy RG; Waldman A; Zhang G; Mitchell A; Tedla N; Cai H; Geczy CR; Chesterman CN; Perry M; Khachigian LM
Nat Biotechnol; 2006 Jul; 24(7):856-63. PubMed ID: 16823369
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.
Yang J; Zhang J; Xing J; Shi Z; Han H; Li Q
Int J Nanomedicine; 2019; 14():6371-6385. PubMed ID: 31496692
[TBL] [Abstract][Full Text] [Related]
16. DNAzymes Dz13 target the c-jun possess antiviral activity against influenza A viruses.
Zhang Z; Zhang S; Wang S
Microb Pathog; 2017 Feb; 103():155-161. PubMed ID: 28039102
[TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
18. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
Engelmann D; Pützer BM
Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of E2F1 during ER stress is required to induce apoptosis.
Pagliarini V; Giglio P; Bernardoni P; De Zio D; Fimia GM; Piacentini M; Corazzari M
J Cell Sci; 2015 Mar; 128(6):1166-79. PubMed ID: 25616897
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
